Does metabolic syndrome influence short and long term durability of carotid endarterectomy and stenting?
<br/><strong>Aims: </strong>The metabolic syndrome (MetS) is composed of a cluster of related cardiovascular risk factors. The aim of the present study was to determine how MetS contributes to short‐ (30‐day) and long‐term complications and restenosis after carotid endarterectomy (...
Κύριοι συγγραφείς: | Casana, R, Malloggi, C, Tolva, V, Odero, A, Bulbulia, R, Halliday, A, Silani, V |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Wiley
2018
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre
ανά: Casana, R, κ.ά.
Έκδοση: (2018) -
Antiplatelet therapy in carotid artery stenting and carotid endarterectomy in the asymptomatic carotid surgery trial-2
ανά: Huibers, A, κ.ά.
Έκδοση: (2015) -
Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
ανά: Giannoukas, A, κ.ά.
Έκδοση: (2014) -
The Asymptomatic Carotid Surgery Trial-2 (ACST-2): An ongoing randomised trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke
ανά: Bulbulia, R, κ.ά.
Έκδοση: (2017) -
Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time
ανά: Lokuge, K, κ.ά.
Έκδοση: (2017)